You Are Here: AHRQ Home > Clinical Information > EPC Evidence Reports > Pharmacological Treatment of Dementia (Table 1)

Pharmacological Treatment of Dementia

Table 1. Pharmacological Interventions and the Number of Trials (#) Evaluated in this Systematic Review

Cholinergic Neurotransmitter Modifying Agents	Non-cholinergic Neurotransmitter/neuropeptide Modifying Agents	Other Agents
Antagonic Stress (2) Acetyl-L-Carnitine (6) Donepezil (11) Eptastigmine (2) Galantamine (6) Huperzine-A (2) Linopirdine (2) Mexofenoxate (1) Metrifonate (9) Nicergoline (5) Physostigmine (4) Posatirelin (4) Rivastigmine (6) Sabeluzole (1) Tacrine (8) Velnacrine (3)	Alaproclate (1) Alprazolam (1) Anapsos (1) BMY (Nootropic) (1) Carbamazepine (2) Citalopram (2) Diphenhydramine (1) Divalproex (2) Fluoxetine (2) Fluvoxamine (1) Haloperidol (8) Imipramine (1) Lisuride (1) Lorazepam (2) Loxapine (2) Lu25-109 (1) Maprotiline (1) Melperone (1) Memantine (3) Mianserin (1) Minaprine (1) Moclobemide (1) Naftidrofuryl (1) Olanzapine (2) Oxazepam (1) Paroxetine (1) Perphenazine (1) Phosphatidylserine (2) Risperidone (2) Selegiline (6) Sertraline (2) Thioridazine (1) Tiapride (2) Trazodone (2) Xanomeline (1)	5'-MTHF (1) Aniracetam (1) Amitriptyline (1) Ateroid (1) Buflomedil (1) Cerebrolysin (6) Choro-San (1) Choto-San (1) Citicoline (2) Cyclandelate (2) Denbufylline (1) Desferrioxamine (1) Diclofenac (1) Ergokryptine (CMB 36-733) (1) Ergokryptine (Dek) (1) Estrogens (5) Ginkgo Biloba (3) Glycosaminoglycan Polysulfate (1) Guanfacine (1) Hydergine (1) Hydroxychloroquine (1) Idebenone (5) Indomethacin (1) Misoprostol (1) Monosialotetrahexosylganglioside (GM-1) (1) N-Acetylcysteine (1) Nimesulide (1) Nimodipine (2) Nizatidine (1) Nootropic (1) ORG 2766 (2) Oxiracetam (5) Pentoxifylline (4) Piracetam (1) Prednisone (1) Propentofylline (4) Pyritinol (1) Silymarin + Tacrine (1) Simvastatin (1) Sulphomucopolysaccharides (1) Sulodexide (1) Thiamine (1) Vasopressin (DDAVP) (1) Vincamine (1) Vitamin E (2) Xantinolnicotinate (1)

Return to Document